Kesavadev Jothydev, Misra Anoop, Saboo Banshi, Agarwal Sanjay, Sosale Aravind, Joshi Shashank R, Hussain Akhtar, Somasundaram Noel, Basit Abdul, Choudhary Pratik, Soegondo Sidartawan
Jothydev's Diabetes Research Centers, Kerala, India.
Chairman, Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Chairman, National Diabetes, Obesity and Cholesterol Foundation (N-DOC) President, Diabetes Foundation, (DFI), India.
Diabetes Metab Syndr. 2022 Jan;16(1):102345. doi: 10.1016/j.dsx.2021.102345. Epub 2021 Nov 22.
The prevalence of diabetes is on its rise and South Asia bears a huge burden. Several factors such as heterogeneity in genetics, socio-economic factors, diet, and sedentary behavior contribute to the heightened risk of developing diabetes, its rapid progression, and the development of complications in this region. Even though there have been considerable advances in glucose monitoring technologies, diabetes treatments and therapeutics, glycemic control in South Asia remains suboptimal. The successful implementation of treatment interventions and metrics for the attainment of glycemic goals depends on appropriate guidelines that accord with the characteristics of the diabetes population.
The data were collected from studies published for more than the last ten years in the electronic databases PubMed and Google Scholar on the various challenges in the assessment and achievement of recommended TIR targets in the SA population using the keywords: Blood glucose, TIR, TAR, TBR, HbA1c, hypoglycemia, CGM, Gestational diabetes mellitus (GDM), and diabetes.
The objective of this recommendation is to discuss the limitations in considering the IC-TIR Expert panel recommendations targets and to propose some modifications in the lower limit of TIR in older/high-risk population, upper limit of TAR, and flexibility in the percentage of time spent in TAR for pregnant women (GDM, T2DM) for the South Asian population.
The review sheds insights into some of the major concerns in implementing the IC-TIR recommendations in South Asian population where the prevalence of diabetes and its complications are significantly higher and modifications to the existing guidelines for use in routine clinical practice.
糖尿病的患病率正在上升,南亚地区负担沉重。遗传异质性、社会经济因素、饮食和久坐不动的行为等多种因素导致该地区患糖尿病的风险增加、病情快速进展以及并发症的发生。尽管血糖监测技术、糖尿病治疗方法和疗法取得了显著进展,但南亚地区的血糖控制仍不理想。成功实施治疗干预措施和实现血糖目标的指标取决于符合糖尿病患者群体特征的适当指南。
从电子数据库PubMed和谷歌学术中收集过去十年以上发表的研究数据,这些研究使用关键词“血糖”“TIR”“TAR”“TBR”“糖化血红蛋白”“低血糖”“连续血糖监测”“妊娠期糖尿病(GDM)”和“糖尿病”,探讨了南亚人群评估和实现推荐的TIR目标所面临的各种挑战。
本建议的目的是讨论在考虑IC-TIR专家小组建议目标时存在的局限性,并针对南亚人群提出一些修改建议,包括老年/高危人群TIR下限、TAR上限以及孕妇(GDM、T2DM)TAR时间百分比的灵活性。
该综述揭示了在糖尿病及其并发症患病率显著更高的南亚人群中实施IC-TIR建议时的一些主要问题,以及对现有指南进行修改以用于常规临床实践的情况。